Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_assertion type Assertion NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_head.
- NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_assertion description "[By performing systematic biochemical and bioinformatical analyses, we identified two miR-221 targets, HECTD2 and RAB1A, which could mediate the development of CRPC phenotype in multiple prostate cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_provenance.
- NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_assertion evidence source_evidence_literature NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_provenance.
- NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_assertion SIO_000772 23770851 NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_provenance.
- NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_assertion wasDerivedFrom befree-2016 NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_provenance.
- NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_assertion wasGeneratedBy ECO_0000203 NP1086291.RAoNW2Esgn1lfRGO6U02oSu-hioO0ztP_FJJ7UKOUXPfY130_provenance.